This content is machine translated Sponsored Content Semaglutide – a modern GLP-1 analogue in type 2 diabetes People with type 2 diabetes have too little endogenous GLP-1 (glucagon-like peptide 1). Semaglutide, which mimics natural GLP-1, can compensate.1 Like endogenous GLP-1, it normalizes blood glucose, supports weight loss,…
View Post 2 min This content is machine translated Diabetes Cases Diabetes treatment for increased risk to heart and kidney How should a typical diabetic patient, 55-year-old, obese, with hypertension, dyslipidemia, and reduced renal function be treated?
View Post 6 min This content is machine translated Type 2 diabetes Better quality of life thanks to modern diabetes therapy The cardiovascular benefit of SGLT2 inhibitors and GLP1 analogues is now considered established, and non-diabetics may also benefit. For optimal results, therapy should be tailored to individual patient characteristics.
View Post 2 min This content is machine translated Biologics for psoriasis Head-to-head study delivers exciting results Interleukin-23 and interleukin-17A play an important role in the inflammatory process of plaque psoriasis. A comparison of two agents directed against these targets in moderate to severe plaque psoriasis led…
View Post 4 min This content is machine translated Diabetes Cases Prevention of cardiovascular events in type 2 diabetes. Type 2 diabetes mellitus (T2DM) is associated with a greatly increased risk of cardiovascular disease [1]. The joint management of T2DM and the cardiovascular risks has therefore come into focus…
View Post 1 min This content is machine translated Online training Swiss Oncology in Motion Module: COVID-19 and oncology patients There are no evidence-based recommendations for the management of tumor patients in corona crisis. The procedure is based worldwide on rational considerations and analogies. Through careful observations and exchange of… CME-Test
View Post 3 min This content is machine translated Diabetic nephropathy Inhibition of sodium-glucose transporter type 2 has a renoprotective effect Diabetic nephropathy is the most common cause of chronic kidney failure – and one of the most common consequences of diabetes mellitus. The introduction of sodium-glucose transporter type 2 (SGLT2)…
View Post 3 min This content is machine translated Diabetes Cases Multifactorial treatment of type 2 diabetes mellitus A 36-year-old obese patient wants to focus more on therapy for his type 2 diabetes mellitus and weight after his thyroidectomy. He also suffers from hypertension and dyslipidemia, which must…
View Post 4 min This content is machine translated Rheumatoid arthritis New JAK inhibitor raises hopes Treatment with disease-modifying antirheumatic drugs (DMARDs) plays an important role in modern therapeutic concepts for rheumatoid arthritis. If left untreated, joint destruction and loss of mobility are possible consequences of…
View Post 2 min This content is machine translated Editorial Swiss Oncology in Motion: Video-based online training courses Educational films in various modules for medical oncologists, hematologists and oncology specialists. Oncology is on the move – research is advancing rapidly and new insights into biology and therapy are…
View Post 1 min This content is machine translated Online training Swiss Oncology in Motion Chronic Lymphocytic Leukemia Module The Chronic Lymphocytic Leukemia module of Swiss Oncology in Motion includes articles by Prof. em. Richard Herrmann, MD, moderated presentations by PD Jeroen S. Goede, MD, Head of Hematology (Head…
